Phase I and II SBIR Grants Issued to Biosearch
News Jun 18, 2007
Biosearch Technologies, Inc. (BTI) has announced that two staff scientists have been awarded Small Business Innovation Research (SBIR) Grants by the National Institutes of Health (NIH) in Bethesda, Maryland.
The first, a $750,000 SBIR Phase II grant funded by the National Institute of General Medical Sciences (NIGMS), will fund the development of fluorescence-based reporter assays incorporating a recently discovered azoreductase that has been shown to release high-quality fluorescent signals. This work has important implications for significantly increasing the data generated by existing high-throughput drug screening technologies through the multiplexing of two or more reporter assays in one screening run.
The second, a $100,000 SBIR Phase I grant again funded by the National Institute of General Medical Sciences (NIGMS), will fund the development of technology for engineering bacterial chromosomes utilizing synthetic DNA. Outgrowths of this technology will enable the facile engineering of bacterial strains for a variety of applications including bioremediation, natural products and biofuel production.
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing OrganizationNews
Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..READ MORE
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE
BOC Sciences Continues to Enlarge Its Publication Collection Using BOC Sciences ProductsNews
BOC Sciences continues to add more publication items that used BOC Sciences products in their researches to its already existing collection.READ MORE